146 related articles for article (PubMed ID: 29383946)
1. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity.
Sulaiman GM; Jabir MS; Hameed AH
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):708-720. PubMed ID: 29383946
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity.
Ali SH; Sulaiman GM; Al-Halbosiy MMF; Jabir MS; Hameed AH
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):378-394. PubMed ID: 30691314
[TBL] [Abstract][Full Text] [Related]
3. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line.
Anari E; Akbarzadeh A; Zarghami N
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1410-6. PubMed ID: 26148177
[TBL] [Abstract][Full Text] [Related]
4. Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles.
Kim KM; Lim HK; Shim SH; Jung J
Int J Nanomedicine; 2017; 12():1917-1925. PubMed ID: 28331315
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of novel P(HEMA-LA-MADQUAT) micelles for co-delivery of methotrexate and Chrysin in combination cancer chemotherapy.
Davaran S; Fazeli H; Ghamkhari A; Rahimi F; Molavi O; Anzabi M; Salehi R
J Biomater Sci Polym Ed; 2018 Aug; 29(11):1265-1286. PubMed ID: 29560796
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation.
Mohammadian F; Abhari A; Dariushnejad H; Zarghami F; Nikanfar A; Pilehvar-Soltanahmadi Y; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(18):8259-63. PubMed ID: 26745070
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of Chrysin-Phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity.
Komath S; Garg A; Wahajuddin M
J Microencapsul; 2018 Sep; 35(6):600-617. PubMed ID: 30557060
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment.
Chevalier MT; Garona J; Sobol NT; Farina HG; Alonso DF; Álvarez VA
Nanomedicine (Lond); 2018 Nov; 13(22):2835-2849. PubMed ID: 30430901
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
Kadari A; Gudem S; Kulhari H; Bhandi MM; Borkar RM; Kolapalli VR; Sistla R
Drug Deliv; 2017 Nov; 24(1):224-232. PubMed ID: 28156161
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells.
Ersoz M; Erdemir A; Duranoglu D; Uzunoglu D; Arasoglu T; Derman S; Mansuroglu B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):319-329. PubMed ID: 30688095
[TBL] [Abstract][Full Text] [Related]
11. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.
Mohammadian F; Pilehvar-Soltanahmadi Y; Mofarrah M; Dastani-Habashi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1972-1978. PubMed ID: 26772615
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective role of chrysin-loaded poly(lactic-co-glycolic acid) nanoparticle against kindling-induced epilepsy through Nrf2/ARE/HO-1 pathway.
Zhang Y; Zhao J; Afzal O; Kazmi I; Al-Abbasi FA; Altamimi ASA; Yang Z
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22634. PubMed ID: 32991785
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity evaluation of novel chrysin-organotin compound in MCF-7 cells.
Xuan HZ; Zhang JH; Wang YH; Fu CL; Zhang W
Bioorg Med Chem Lett; 2016 Jan; 26(2):570-574. PubMed ID: 26670842
[TBL] [Abstract][Full Text] [Related]
14. Directional modification of chrysin for exerting apoptosis and enhancing significantly anti-cancer effects of 10-hydroxy camptothecin.
Tang Q; Ji F; Guo J; Wang J; Li Y; Bao Y
Biomed Pharmacother; 2016 Aug; 82():693-703. PubMed ID: 27470413
[TBL] [Abstract][Full Text] [Related]
15. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P
Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
[TBL] [Abstract][Full Text] [Related]
18. Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model.
Tavakoli F; Jahanban-Esfahlan R; Seidi K; Jabbari M; Behzadi R; Pilehvar-Soltanahmadi Y; Zarghami N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):75-86. PubMed ID: 29607740
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles.
Zou L; Chen F; Bao J; Wang S; Wang L; Chen M; He C; Wang Y
Drug Deliv; 2016; 23(3):908-16. PubMed ID: 24904975
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
